Reported Apr 21, 2021 · Ongoing
Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by:…
Asclemed USA Inc. dba Enovachem Pharmaceuticals
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Asclemed USA Inc. dba Enovachem Pharmaceuticals · 379 Van Ness Ave Ste 1403 · Torrance, CA · 90501-7211
Is this the product you have?
- Distributed byDocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister
- NDC69306-004-21
- Relabeled byEnovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501
- Manufactured byJubilant Cadista Pharmaceuticals Inc
- Source NDC59746-001-03, DocRx, Mobile, AL 36608
- Lot codes and dates
Lot #: 20K0043PExp. 8/31/202220L0026PExp. 9/30/2022
- Amount recalled
- N/A
Where it was sold
Why it was recalled
Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Asclemed USA Inc. dba Enovachem Pharmaceuticals recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.